New pill could stop rare swelling attacks in their tracks

NCT ID NCT07266805

First seen Dec 16, 2025 · Last updated May 16, 2026 · Updated 20 times

Summary

This study tests an oral medication called deucrictibant for adults with acquired angioedema, a rare condition causing sudden, painful swelling. The drug comes in two forms: a long-acting tablet to prevent attacks and a fast-acting capsule to stop attacks once they start. About 32 participants will receive either the drug or a placebo to see if it safely reduces attack frequency and severity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACQUIRED ANGIOEDEMA DUE TO C1-INHIBITOR DEFICIENCY (AAE-C1-INH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Study List

    RECRUITING

    Milan, Italy

  • Study Site

    RECRUITING

    Walnut Creek, California, 94598,, United States

  • Study Site

    RECRUITING

    Walnut Creek, California, 94598, United States

  • Study Site

    RECRUITING

    St Louis, Missouri, 63130, United States

  • Study Site

    RECRUITING

    Sofia, Bulgaria

  • Study Site

    RECRUITING

    Edmonton, Canada

  • Study Site

    RECRUITING

    Paris, France

  • Study Site

    RECRUITING

    Berlin, Germany

  • Study Site

    RECRUITING

    Frankfurt am Main, Germany

  • Study Site

    RECRUITING

    Munich, Germany

  • Study Site

    RECRUITING

    Budapest, Hungary

  • Study Site

    RECRUITING

    Basel, Switzerland

  • Study Site

    RECRUITING

    Cambridge, United Kingdom

  • Study Site

    RECRUITING

    Leicester, United Kingdom

  • Study Site

    RECRUITING

    London, United Kingdom

  • Study Site

    RECRUITING

    Newcastle upon Tyne, United Kingdom

  • Study Site

    RECRUITING

    Plymouth, United Kingdom

Conditions

Explore the condition pages connected to this study.